SARS coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, emerged in China in
December 2019. Vaccines developed were very effective initially, however, the virus has …

Omicron is the evolutionarily most distinct severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) variant of concern (VOC) to date. We report that Omicron BA. 1 breakthrough …

Abstract The SARS-CoV-2 Omicron variant exhibits striking immune evasion and is
spreading rapidly worldwide. Understanding the structural basis of the high transmissibility …

Spike glycoprotein of SARS-CoV-2 mediates viral entry into host cells by facilitating virus
attachment and membrane fusion. ACE2 is the main receptor of SARS-CoV-2 and its …

BNT162b2-vaccinated individuals after Omicron BA. 1 breakthrough infection have strong
serum-neutralizing activity against Omicron BA. 1, BA. 2, and previous SARS-CoV-2 variants …

SARS-CoV-2 spike glycoprotein mediates receptor binding and subsequent membrane
fusion. It exists in a range of conformations, including a closed state unable to bind the ACE2 …

To control the ongoing COVID‐19 pandemic, a variety of severe acute respiratory syndrome
coronavirus 2 (SARS‐CoV‐2) vaccines have been developed. However, the rapid mutations …

Among the current five Variants of Concern, infections caused by SARS-CoV-2 B. 1.617. 2
(Delta) variant are often associated with the greatest severity. Despite recent advances on …

The structure of the sulfated galactan from the red alga Botryocladia occidentalis (BoSG)
was originally proposed as a simple repeating disaccharide of alternating 4-linked α …

In the present work we studied the antiviral activity of the home library of monoterpenoid
derivatives using the pseudoviral systems of our development, which have glycoproteins of …